Differential expression of BIRC family genes in chronic myeloid leukaemia--BIRC3 and BIRC8 as potential new candidates to identify disease progression

Br J Haematol. 2014 Mar;164(5):740-2. doi: 10.1111/bjh.12663. Epub 2013 Nov 25.

Authors

Eliza Glodkowska-Mrowka¹, Iwona Solarska, Piotr Mrowka, Katarzyna Bajorek, Joanna Niesiobedzka-Krezel, Ilona Seferynska, Katarzyna Borg, Tomasz Stoklosa

Affiliation

¹ Department of Immunology, Medical University of Warsaw, Warsaw, Poland; Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Warsaw, Poland.

PMID: 24266799
DOI: 10.1111/bjh.12663

No abstract available

Keywords: BIRC3; BIRC8; chronic myeloid leukaemia; prognostic factor; survivin.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Baculoviral IAP Repeat-Containing 3 Protein
Biomarkers, Tumor / biosynthesis*
Disease Progression
Drug Resistance, Neoplasm / genetics
Gene Expression Regulation, Neoplastic
Humans
Inhibitor of Apoptosis Proteins / biosynthesis*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Prognosis
Protein Kinase Inhibitors / therapeutic use
Ubiquitin-Protein Ligases

Substances

BIRC8 protein, human
Biomarkers, Tumor
Inhibitor of Apoptosis Proteins
Protein Kinase Inhibitors
BIRC3 protein, human
Baculoviral IAP Repeat-Containing 3 Protein
Ubiquitin-Protein Ligases